Stryker (NYSE:SYK) is rumored to be in the hunt for ActiViews and its CT-guided lung biopsy device, according to an Israeli newspaper.
HeartWare lands CE Mark for long-term heart pump implant | Regulatory Roundup
AngioDynamics resumes NanoKnife shipments following FDA warning | Regulatory Roundup
St. Jude’s Ilumien hybrid wins CE Mark | Regulatory Roundup
St. Jude Medical Inc. (NYSE:STJ) landed CE Mark approval in the European Union for what it bills as the first and only hybrid diagnostic imaging system to combine optical coherence tomography and fractional flow reserve technology into a single platform.